A Novel Approach to Contrast-Enhanced Breast Magnetic Resonance Imaging for Screening: High-Resolution Ultrafast Dynamic Imaging
暂无分享,去创建一个
Nico Karssemeijer | Bram Platel | Jan van Zelst | Christian Geppert | N. Karssemeijer | B. Platel | C. Geppert | R. Mann | R. Mus | J. V. van Zelst | Ritse M. Mann | Roel D. Mus
[1] Karl-Heinz Herrmann,et al. Resolving arterial phase and temporal enhancement characteristics in DCE MRM at high spatial resolution with TWIST acquisition , 2011, Journal of magnetic resonance imaging : JMRI.
[2] C. Flowers,et al. Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population , 2009, BMC health services research.
[3] Yuan Le,et al. Development and evaluation of TWIST Dixon for dynamic contrast‐enhanced (DCE) MRI with improved acquisition efficiency and fat suppression , 2012, Journal of magnetic resonance imaging : JMRI.
[4] L J van Erning,et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. , 1994, Radiology.
[5] Wei Huang,et al. A feasible high spatiotemporal resolution breast DCE-MRI protocol for clinical settings. , 2012, Magnetic resonance imaging.
[6] R. Mann,et al. Ductal carcinoma in situ and breast MRI , 2007, The Lancet.
[7] G Lutterbey,et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. , 1997, Radiology.
[8] C. Kuhl. Breast MR imaging at 3T. , 2007, Magnetic resonance imaging clinics of North America.
[9] J. Klijn,et al. Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer , 2006, Breast Cancer Research and Treatment.
[10] H. Niendorf,et al. Tolerance data of Gd-DTPA: a review. , 1991, European journal of radiology.
[11] B. Hamm,et al. Pharmacokinetic Approach for Dynamic Breast MRI to Indicate Signal Intensity Time Curves of Benign and Malignant Lesions by Using the Tumor Flow Residence Time , 2013, Investigative radiology.
[12] Nico Karssemeijer,et al. Automated Characterization of Breast Lesions Imaged With an Ultrafast DCE-MR Protocol , 2014, IEEE Transactions on Medical Imaging.
[13] H. Bieling,et al. Accelerated breast MRI for breast cancer screening. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] M. Hallquist,et al. Anticipatory psychological distress in women scheduled for diagnostic and curative breast cancer surgery. , 2008, International Journal of Behavioral Medicine.
[15] Usha Sinha,et al. In vivo diffusion‐weighted MRI of the breast: Potential for lesion characterization , 2002, Journal of magnetic resonance imaging : JMRI.
[16] Henkjan Huisman,et al. Comparison of enhancement characteristics between invasive lobular carcinoma and invasive ductal carcinoma , 2011, Journal of magnetic resonance imaging : JMRI.
[17] Wolfgang Bogner,et al. A Combined High Temporal and High Spatial Resolution 3 Tesla MR Imaging Protocol for the Assessment of Breast Lesions: Initial Results , 2009, Investigative radiology.
[18] Qingli Zhu,et al. Differentiation of Benign and Malignant Sub‐1‐cm Breast Lesions Using Contrast‐Enhanced Sonography , 2015, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[19] Katarzyna J Macura,et al. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. , 2010, Radiology.
[20] J. Austoker,et al. The psychological impact of mammographic screening. A systematic review , 2005, Psycho-oncology.
[21] A R Padhani,et al. Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer , 2006, British Journal of Cancer.
[22] Wendy B DeMartini,et al. BI‐RADS MRI Enhancement Characteristics of Ductal Carcinoma In Situ , 2007, The breast journal.
[23] Daniel B Kopans,et al. Physiologic Changes in Breast Magnetic Resonance Imaging during the Menstrual Cycle: Perfusion Imaging, Signal Enhancement, and Influence of the T1 Relaxation Time of Breast Tissue , 2005, The breast journal.
[24] C. Geppert,et al. Application of time‐resolved angiography with stochastic trajectories (twist)‐dixon in dynamic contrast‐enhanced (dce) breast mri , 2013, Journal of magnetic resonance imaging : JMRI.
[25] Peter Reimer,et al. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines , 2013, European Radiology.
[26] H. D. de Koning,et al. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging. , 2013, Journal of the National Cancer Institute.
[27] G. Oster,et al. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women. , 2009, Journal of the American College of Radiology : JACR.
[28] Roberto Orecchia,et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. , 2010, European journal of cancer.
[29] F. Sardanelli,et al. Breast MRI using a high-relaxivity contrast agent: an overview. , 2011, AJR. American journal of roentgenology.
[30] Jeffrey D Blume,et al. Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. , 2010, Radiology.
[31] Maximilian Reiser,et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] Karel G M Moons,et al. Meta-analysis of MR imaging in the diagnosis of breast lesions. , 2008, Radiology.
[33] M. Yaffe,et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.
[34] W. J. Lorenz,et al. Pharmacokinetic Mapping of the Breast: A New Method for Dynamic MR Mammography , 1995, Magnetic resonance in medicine.
[35] P. Salkovskis,et al. Claustrophobia in MRI: the role of cognitions. , 2008, Magnetic resonance imaging.
[36] Wei Huang,et al. Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging. , 2011, Radiology.
[37] W. Kaiser,et al. The Necrosis Sign in Magnetic Resonance‐Mammography: Diagnostic Accuracy in 1,084 Histologically Verified Breast Lesions , 2010, The breast journal.
[38] Simone Schrading,et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study , 2007, The Lancet.
[39] W. Kaiser,et al. Nonmass Lesions in Magnetic Resonance Imaging of the Breast: Additional T2-Weighted Images Improve Diagnostic Accuracy , 2011, Journal of computer assisted tomography.
[40] P S Tofts,et al. Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model , 1995, Magnetic resonance in medicine.
[41] Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers , 2013, BMC Cancer.
[42] C. Balleyguier,et al. Computed-aided diagnosis (CAD) in the detection of breast cancer. , 2013, European journal of radiology.
[43] G P Liney,et al. Differentiation of benign and malignant sub-1 cm breast lesions using dynamic contrast enhanced MRI. , 2004, Breast.
[44] C. Catalano,et al. Effect of Preoperative Breast Magnetic Resonance Imaging on Surgical Decision Making and Cancer Recurrence Rates , 2012, Investigative radiology.
[45] C. Kuhl,et al. Mammographic, US, and MR imaging phenotypes of familial breast cancer. , 2008, Radiology.
[46] C. Boetes,et al. Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions , 2008, European Radiology.
[47] Wendy B DeMartini,et al. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement. , 2009, AJR. American journal of roentgenology.
[48] W E Reddick,et al. Evolution from empirical dynamic contrast-enhanced magnetic resonance imaging to pharmacokinetic MRI. , 2000, Advanced drug delivery reviews.
[49] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[50] M. Knopp,et al. Dynamic contrast‐enhanced MRI using Gd‐DTPA: Interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors , 2001, Magnetic resonance in medicine.
[51] Ning-Yu An,et al. Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging , 2002, Journal of magnetic resonance imaging : JMRI.
[52] C. Boetes,et al. Breast MRI: guidelines from the European Society of Breast Imaging , 2008, European Radiology.
[53] N. Hylton,et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. , 2006, Radiology.